Ortho tri-cyclen and Breast cancer - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Ortho Tri-cyclen?
Ortho tri-cyclen has active ingredients of ethinyl estradiol; norgestimate. It is used in birth control. Currently, eHealthMe is studying from 5,696 Ortho tri-cyclen users.
What is Breast Cancer?
Breast cancer is found to be associated with 2,468 drugs and 1,609 conditions by eHealthMe. Currently, we are studying 255,487 people who have Breast cancer.
Do you take Ortho tri-cyclen and have Breast cancer?Check whether Breast cancer is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Ortho tri-cyclen side effects by duration, gender and age:
- Ortho tri-cyclen side effects (5,696 reports)
Breast cancer treatments and more:
- Breast cancer (255,487 reports)
All the drugs that are associated with Breast cancer:
All the conditions that are associated with Breast cancer:
How the study uses the data?
The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate (the active ingredients of Ortho tri-cyclen) and Ortho tri-cyclen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Peridex and Colcrys drug interaction - a second ago
- Prilosec and Chronic Fatigue Syndrome - 15 seconds ago
- Catapres and Hyperthyroidism - 20 seconds ago
- Navane and Cymbalta drug interaction - 20 seconds ago
- Actigall and Muscle Aches - 37 seconds ago
- Terconazole and Ondansetron drug interaction - 53 seconds ago
- Amoxicillin and Tumor Marker Increased - a minute ago
- Posaconazole and Mouth Ulcers - a minute ago
- Glucosamine and Etoposide drug interaction - a minute ago
- Lisinopril and Transfusion-Related Circulatory Overload - a minute ago